Immunocore Holdings plc
IMCR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,475 | $3,340 | $2,157 | $1,075 |
| - Cash | $456 | $443 | $333 | $238 |
| + Debt | $433 | $84 | $69 | $64 |
| Enterprise Value | $1,452 | $2,982 | $1,894 | $901 |
| Revenue | $248 | $249 | $144 | $36 |
| % Growth | -0.7% | 72.9% | 295.3% | – |
| Gross Profit | $239 | $248 | $139 | $36 |
| % Margin | 96.6% | 99.6% | 96.3% | 100% |
| EBITDA | -$39 | -$52 | -$38 | -$167 |
| % Margin | -15.5% | -20.7% | -26.6% | -457% |
| Net Income | -$41 | -$55 | -$43 | -$180 |
| % Margin | -16.5% | -22.2% | -30.1% | -493.4% |
| EPS Diluted | -1.02 | -1.13 | -0.95 | -3 |
| % Growth | 9.7% | -18.9% | 68.3% | – |
| Operating Cash Flow | $26 | $3 | -$49 | -$143 |
| Capital Expenditures | -$5 | -$5 | -$2 | -$1 |
| Free Cash Flow | $21 | -$2 | -$51 | -$144 |